Patients in the US face an average annual out-of-pocket expense of $1027 for medications alone, creating severe financial barriers that impair adherence to necessary therapies for peripheral arterial disease (PAD). According to research published in The Lancet on September 1, 2026, these mounting costs and subsequent diagnostic delays often allow the condition to progress to major lower-limb amputations, which carry a devastating 50% job loss rate among affected individuals.
Integrated Team-Based Management to Combat PAD Outcomes
To combat alarming amputation and job loss rates, health care delivery must shift away from relying primarily on surgical revascularization and move toward integrated, team-based medical management. Within cardiometabolic teams, pharmacists are ideally situated to act as essential care extenders, filling critical patient care gaps by dedicating 30 minutes to follow-up appointments and up to an hour for initial evaluations. This extra time dwarfs traditional 15-minute physician visits, offering ample space for essential patient education.
Through collaborative practice agreements, pharmacists help eliminate therapeutic inertia by optimizing drug regimens, adjusting dosages for renal function, and working around medication coverage barriers. This extended clinical touchpoint helps ensure that patients maintain adherence to lifestyle modifications and complex drug regimens, according to analyses by R. Peroutky and E. Schmidt published in April 2026.
Advanced Antithrombotic Strategies and Pharmacy Interventions
Recent landmark clinical trials have revolutionized the pharmacological management of PAD. Evidence from major clinical trials such as VOYAGER-PAD (NCT02504216) and COMPASS (NCT01776424) indicates that the use of low-dose aspirin combined with low-dose rivaroxaban at 2.5 milligrams twice a day lowers major amputations by up to 70% and major adverse cardiovascular events (MACE) by 28% when compared to aspirin used alone.
Community pharmacists play an essential role in guiding patients on over-the-counter aspirin selection and preventing harmful drug interactions from duplicate therapies. Z. notes that pharmacists also participate in disease prevention by establishing medication synchronization programs, setting realistic weight-loss goals, promoting structured physical activity, and implementing smoking cessation programs based on the 5 A’s framework in a 2023 review in the Journal of Clinical Pharmacy and Therapeutics.
Clinical Practice Insights
Did you know? Students in pharmacy schools are now taught to utilize handheld Doppler devices to measure the ankle-brachial index, which enables pharmacists in outpatient and community settings to screen high-risk patients before surgical intervention becomes necessary due to disease progression.
Frontline Screening and Diagnostic Hurdles in High-Risk Patients
Beyond medication management, pharmacists are expanding their clinical scope into early disease identification and noninvasive screening. In patients with diabetes or chronic kidney disease, arterial calcification causes noncompressible ankle vessels. In these instances, pharmacists recognize the need for alternative diagnostic tools like the toe-brachial index, as detailed by H. Hayes Jr. and colleagues in U.S. Pharmacist.
By identifying at-risk patients during routine encounters and conducting thorough medication reviews, pharmacists serve as an indispensable defense against disease progression and health inequities in the cardiometabolic space. The authors of the September 2026 The Lancet report concluded that health care systems require revisions to improve the reimbursement of early-stage disease treatment, enhance the training of specialists in PAD medical care, and integrate standalone multidisciplinary models for providing rehabilitation and medical care.
Common Questions Regarding Pharmacist-Led PAD Care
How much do out-of-pocket medication costs impact PAD patients?
For medications alone, US patients spend an average of $1027 out-of-pocket annually, creating financial hurdles that increase the risk of disease progression and severely hinder adherence to required therapies.
What clinical trial evidence supports combination antithrombotic therapy for PAD?
Data from the COMPASS and VOYAGER-PAD trials show that combining low-dose rivaroxaban at 2.5 milligrams twice daily with low-dose aspirin reduces major adverse cardiovascular events by 28% and major amputations by up to 70% compared with aspirin alone.
How do pharmacists contribute to early detection of peripheral arterial disease?
Pharmacists utilize handheld Doppler devices to measure the ankle-brachial index in high-risk individuals, and they identify instances of arterial calcification where alternative diagnostics like the toe-brachial index are required.
What specialized training do pharmacists use for lifestyle interventions?
Pharmacists implement structured smoking cessation programs using the 5 A’s framework, promote physical activity, set realistic weight-loss goals, and establish medication synchronization programs to support long-term adherence.